European Archives - Page 96 of 1211 - European Medical Journal

New Muscle Reference Values Improve Sarcopenia Screening

Researchers have established standardised global cutoffs for skeletal muscle index and density on abdominal CT in healthy young adults, aiding early sarcopenia detection.

Armoured CAR T-Cell Therapy Shows Promise in Resistant Lymphoma

A novel form of CAR T-cell therapy, engineered to enhance immune response, is showing encouraging results in patients with relapsed or refractory lymphoma who previously failed anti-CD19 CAR T-cell treatment.

Joan Carles

Onc Now: Episode 17: Breaking New Ground in Genitourinary Cancer Treatment

Joan Carles, Vall d’Hebron, shares insights on anti-angiogenic therapies, resistance in GU cancers, and the future of personalised oncology.

Mental Health Decline Observed in Metabolic Disease Patients Post-Pandemic

A recent study utilizing UK Biobank data has identified a significant rise in new-onset mental health disorders—specifically depression, anxiety, and alcohol use disorders—among adults with metabolic diseases such as hypertension, diabetes, and obesity in the aftermath of the COVID-19 pandemic.

New Immune Therapy Effective in Acute Lymphoblastic Leukaemia

A novel CAR T cell therapy has shown encouraging results in children and adults with relapsed/refractory B-cell acute lymphoblastic leukaemia.

ESCMID Global 2025 Interview: F-Xavier Lescure

The quality of the response depends on the quality of the preparedness phase, particularly today, when we are living in a chronic and…

Iron and Alcohol Interactions Drive Liver Disease Risk

A new retrospective study has proposed a predictive model for cirrhosis and hepatocellular carcinoma in individuals with haemochromatosis.

New investor network targets women’s health gap

WHAM’s Innovator’s Circle unites top funds to address the women’s health investment gap.

Oral Azithromycin Prescribing Practices for Community-Acquired Pneumonia

This study provides a timely examination of antibiotic prescribing practices in the emergency department, a critical frontline in the…

Survival Factors in Colorectal Cancer with Immune Checkpoint Inhibitors

A new study of 18,932 metastatic colorectal cancer patients reveals that microsatellite instability, albumin levels, and antibiotic use significantly impact survival rates when treated with immune checkpoint inhibitors, offering insights for personalised treatment.